Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)

por Dearnaley, D P, Fossa, S D, Kaye, S B, Cullen, M H, Harland, S J, Sokal, M P J, Graham, J D, Roberts, J T, Mead, G M, Williams, M V, Cook, P A, Stenning, S P
Publicado 2005